ALB and lung carcinoma: The HSA‐enriched and HSA‐depleted fractions reflect the largest differences between lung cancer and reference samples with p‐values below 10−6 (Table S3), while the metabolite fraction is not significantly different in the samples from reference individuals versus these of the lung cancer patients.